Asrar Alahmadi
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Tarlatamab for the Treatment of Extensive Stage Small-cell Lung Cancer (NCT07423585) | Asrar Alahmadi | 2026-03-20 |
Track Asrar Alahmadi automatically
Every clearance here is in the API, with alerts when new ones post.